The Promise and Challenge of Big Data for Pharma
Harvard Business
NOVEMBER 29, 2016
It will increasingly help government health agencies, payers, and providers to make decisions about such issues as drug discovery, patient access, and marketing. To be sure, anonymized insurance-claims data and electronic health record (EHR) data has been accessed and analyzed for many years.
28 
Let's personalize your content